We have also analyzed the levels of PMN-MDSC (CD15 + CD11b + CD33 + HLA-DRlow) in IVIg-treated CVID patients, but the results were inconclusive, and a larger cohort of CVID patients is required to clarify this issue in future studies. This evidence concerns the gene CD33 and common variable immunodeficiency.